Trump administration
Trump Administration Overhauls Childhood Vaccine Schedule, Reducing Recommendations and Sparking Industry Backlash
vaccine schedule; childhood vaccines; Trump administration; RFK Kennedy; Gardasil HPV; public health debate
FDA Policy Tracker: 2025 Was a Year of Change
FDA; 2025; Trump Administration; Food Safety; FSMA 204; GRAS Reform; Drug Approvals; Recall Improvements
Drugmakers with White House MFN Deals Claim Exemption from Proposed Medicare Pricing Tests
MFN pricing; Trump administration; Medicare pricing; drug pricing deals; exemptions; pharmaceutical companies
White House unveils nine new “most-favored-nation” drug pricing deals
most-favored-nation pricing; MFN; drug pricing; White House; Trump administration; pharmaceutical manufacturers; Ozempic; Wegovy; Eli Lilly; Novo Nordisk; prescription drug costs; US healthcare policy
The Endpoints 100: Biotech CEOs are feeling more upbeat about the road ahead
Endpoints 100; E100 survey; biotech CEOs; biopharma executives; industry sentiment; market recovery; dealmaking; IPO window; Trump administration; FDA reorganization; tariffs; 2025 outlook
UK Agrees to Increase Drug Spending by 25% to Avoid US Pharma Tariffs
UK; United States; drug spending; pharmaceutical tariffs; trade deal; medicine pricing; Trump administration; pharma companies
Lilly and Novo Nordisk Near White House Deal to Cut Obesity Drug Prices
Lilly; Novo Nordisk; White House; obesity drug prices; Medicare coverage; GLP-1 medications; Trump administration; Zepbound; Wegovy
Cigna Announces End to Drug Rebates for Many Health Plans Beginning in 2027
Cigna; drug rebates; pharmacy benefit manager; Evernorth; Express Scripts; upfront discounts; brand-name prescriptions; pharmacy reimbursement; Trump administration; drug pricing
White House Announces New Most-Favored Nation Drug Pricing Deal, Updates on FDA Vouchers and GLP-1 Negotiations
most-favored nation pricing; fertility drugs; IVF; Trump administration; drug pricing; Medicaid; FDA vouchers; GLP-1; EMD Serono; Pfizer; AstraZeneca
White House ‘Most Favored Nation’ Deadline Drives Pharma Concessions Amid Threats of Enforcement
most favored nation; drug pricing; White House; executive order; pharmaceutical companies; Medicaid; Medicare; drug manufacturers; Trump administration; prescription drug costs; deadline; pharma concessions